JP2024532482A5 - - Google Patents

Info

Publication number
JP2024532482A5
JP2024532482A5 JP2024513926A JP2024513926A JP2024532482A5 JP 2024532482 A5 JP2024532482 A5 JP 2024532482A5 JP 2024513926 A JP2024513926 A JP 2024513926A JP 2024513926 A JP2024513926 A JP 2024513926A JP 2024532482 A5 JP2024532482 A5 JP 2024532482A5
Authority
JP
Japan
Prior art keywords
antigen
receptor
cells
binds
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024513926A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532482A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2022/051070 external-priority patent/WO2023028657A1/en
Publication of JP2024532482A publication Critical patent/JP2024532482A/ja
Publication of JP2024532482A5 publication Critical patent/JP2024532482A5/ja
Pending legal-status Critical Current

Links

JP2024513926A 2021-09-01 2022-09-01 免疫活性を刺激するための方法および組成物 Pending JP2024532482A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2021902832A AU2021902832A0 (en) 2021-09-01 Methods and compositions for stimulating immune activity
AU2021902832 2021-09-01
PCT/AU2022/051070 WO2023028657A1 (en) 2021-09-01 2022-09-01 Methods and compositions for stimulating immune activity

Publications (2)

Publication Number Publication Date
JP2024532482A JP2024532482A (ja) 2024-09-05
JP2024532482A5 true JP2024532482A5 (cg-RX-API-DMAC7.html) 2025-08-01

Family

ID=85410590

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024513926A Pending JP2024532482A (ja) 2021-09-01 2022-09-01 免疫活性を刺激するための方法および組成物
JP2024513973A Pending JP2024532489A (ja) 2021-09-01 2022-09-01 新規の機能不全p2x7結合剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024513973A Pending JP2024532489A (ja) 2021-09-01 2022-09-01 新規の機能不全p2x7結合剤

Country Status (8)

Country Link
US (2) US20240368282A1 (cg-RX-API-DMAC7.html)
EP (2) EP4395814A4 (cg-RX-API-DMAC7.html)
JP (2) JP2024532482A (cg-RX-API-DMAC7.html)
CN (2) CN117813109A (cg-RX-API-DMAC7.html)
AU (2) AU2022341030A1 (cg-RX-API-DMAC7.html)
CA (2) CA3223079A1 (cg-RX-API-DMAC7.html)
MX (2) MX2023015469A (cg-RX-API-DMAC7.html)
WO (2) WO2023028657A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016100232A1 (en) * 2014-12-15 2016-06-23 The Regents Of The University Of California Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
CA3195512A1 (en) * 2020-10-14 2022-04-21 Vahe Bedian Compositions and methods for treatment of thyroid eye disease
JP2024531151A (ja) 2021-08-10 2024-08-29 ビリジアン セラピューティクス, インコーポレイテッド 甲状腺眼疾患の処置のための組成物、用量および方法
JP2026507807A (ja) * 2023-03-08 2026-03-06 バイオセプター (オースト) プロプライエタリー・リミテッド 機能不全p2x7受容体に結合するためのキメラ抗原受容体
WO2024211413A2 (en) * 2023-04-05 2024-10-10 Arizona Board Of Regents On Behalf Of The University Of Arizona Trogocytosis in cancer cells and methods for treating cancer related thereto
WO2024220870A1 (en) * 2023-04-19 2024-10-24 The University Of Chicago Antibody-targeted enzymatic chemoprotection
KR20260024373A (ko) * 2023-05-05 2026-02-20 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 다중-수용체 자연 살해 세포
WO2025000037A1 (en) * 2023-06-30 2025-01-02 Biosceptre (Aust) Pty Ltd Molecules and methods for activating car t cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3395832B1 (en) * 2009-08-20 2021-11-24 Biosceptre (Aust) Pty Ltd Anti p2x7 receptor antibodies and fragments thereof
EP2516470B1 (en) * 2009-12-24 2018-02-07 Biosceptre (Aust) Pty Ltd Antibodies to non-functional oligomeric p2x7 receptors
CN107614528A (zh) * 2015-04-02 2018-01-19 生物权威(英国)有限公司 疼痛治疗
US12121539B2 (en) * 2015-09-11 2024-10-22 Biosceptre (Aust) Pty Ltd Chimeric antigen receptors and uses thereof
CN109862883A (zh) * 2016-10-21 2019-06-07 生物权威(英国)有限公司 细胞毒性颗粒
AU2019275479B2 (en) * 2018-05-21 2022-12-08 Biosceptre (Aust) Pty Ltd Chimeric antigen receptors with modified linker domains and uses thereof
WO2020191344A1 (en) * 2019-03-20 2020-09-24 The Regents Of The University Of California Claudin-6 bispecific antibodies
MX2021011750A (es) * 2019-03-27 2021-12-10 Nat Res Council Canada Anticuerpos anti-egfrviii y fragmentos de union a antigenos de los mismos.
CA3211323A1 (en) * 2021-03-11 2022-09-15 Patrick Schlegel Novel cell therapy system

Similar Documents

Publication Publication Date Title
JP7551693B2 (ja) NKp46結合タンパク質の可変領域
JP7550591B2 (ja) 多重特異的NKp46結合タンパク質
JP7611931B2 (ja) ガイダンス及びナビゲーションコントロール(gnc)抗体様タンパク質、その製造方法及び使用方法
JP6971153B2 (ja) 多重特異的nkエンゲイジャータンパク質
WO2020113164A1 (en) Heterodimeric tetravalency and specificity antibody compositions and uses thereof
JP2023518134A5 (cg-RX-API-DMAC7.html)
JP2021525546A5 (cg-RX-API-DMAC7.html)
KR20230143177A (ko) 신규한 항-cd24 항체
JP2024510739A5 (cg-RX-API-DMAC7.html)
JP2023505318A5 (cg-RX-API-DMAC7.html)
CN114206931A (zh) 抗pd-1抗体及其用途
CN116948035A (zh) 多特异性抗体及其制备和使用方法
JP7592712B2 (ja) ガイダンス及びナビゲーションコントロールタンパク質、その製造方法及び使用方法
JP2023544294A5 (cg-RX-API-DMAC7.html)
JP2024541476A5 (cg-RX-API-DMAC7.html)
EP4274605A1 (en) Indinavir based chemical dimerization t cell engager compositions
US20250101104A1 (en) Bispecific molecule with tunable affinity to a targeted antigen
JP2025528835A5 (cg-RX-API-DMAC7.html)
JP2024513485A5 (cg-RX-API-DMAC7.html)
HK40129779A (zh) 制导和导航控制(gnc)抗体样蛋白及其制备和使用方法
HK40129137A (en) Guidance and navigation control (gnc) antibody-like proteins and methods of making and using thereof
HK40070091A (en) Anti-pd-1 antibody and use thereof
HK40073541A (en) Miniature guidance and navigation control (minignc) antibody-like proteins and methods of making and using thereof